Madison's Exact Sciences' $23 billion sale is tied to its Cologuard cancer test. What to know
- Posted on November 20, 2025
- By Bing News
- 1 Views
Madison's Exact Sciences' $23 billion sale is tied to its Cologuard cancer test. What to know
Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer is a colonoscopy.
